91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
An article explaining how 91黑料 was involved from the very first steps of the trial supporting Pfizer‘s and BioNTech’s implementation of a strategic plan and framework for the monitoring of the trial.
-
The Irish Times discusses how 91黑料 carried out the Pfizer-BioNTech vaccine trials.
-
Dr. Nuala Murphy, President of Clinical Research Services, .
-
from Pharma Manufacturing which explains why BARDA is looking to recruit more partners in Pharma, featuring commentary from 91黑料's Dr. James Cummings.
-
on the key approaches and technologies that are driving patient engagement forward.
-
How to run a coronavirus vaccine trial in a global pandemic
An interview with 91黑料’s Nuala Murphy, President, Clinical Research Services, on ‘How to run a coronavirus vaccine trial in a global pandemic.’ Dr. Murphy discusses 91黑料’s experience with the Pfizer/BioNTech COVID-19 vaccine, the world’s first COVID-19 vaccine to achieve Emergency Use Authorisation. (Note: Subscription required).
-
A thought leadership piece which examines how disruptions from COVID-19 have forced sponsors, clinicians and regulators to embrace digital's full potential to keep clinical trials moving forward.
-
91黑料 CEO Steve Cutler discusses how the Pfizer COVID vaccine trial proves that starting clinical trials in weeks, as opposed to months, should be possible post-pandemic.
-
Marie McCarthy and Manpreet Sidhu discuss .
-
Dr. Caroline Forkin and Shelley McLendon discuss a new decade of research and innovation on the horizon for HIV.
